SAM
Shell Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,262
| Closed | -$100K | – | 1280 |
|
|
2023
Q3 | $100K | Sell |
23,262
-363
| -2% | -$1.56K | ﹤0.01% | 1087 |
|
|
2023
Q2 | $156K | Sell |
23,625
-6,899
| -23% | -$45.6K | 0.01% | 1002 |
|
|
2023
Q1 | $207K | Sell |
30,524
-108
| -0.4% | -$732 | 0.01% | 912 |
|
|
2022
Q4 | $226K | Sell |
30,632
-6,423
| -17% | -$47.4K | 0.01% | 912 |
|
|
2022
Q3 | $366K | Sell |
37,055
-9,712
| -21% | -$95.9K | 0.01% | 732 |
|
|
2022
Q2 | $510K | Buy |
46,767
+79
| +0.2% | +$862 | 0.02% | 708 |
|
|
2022
Q1 | $528K | Sell |
46,688
-6,909
| -13% | -$78.1K | 0.01% | 789 |
|
|
2021
Q4 | $841K | Buy |
53,597
+244
| +0.5% | +$3.83K | 0.02% | 648 |
|
|
2021
Q3 | $914K | Sell |
53,353
-2,300
| -4% | -$39.4K | 0.02% | 550 |
|
|
2021
Q2 | $1.2M | Buy |
55,653
+11,753
| +27% | +$253K | 0.02% | 496 |
|
|
2021
Q1 | $659K | Buy |
43,900
+12,068
| +38% | +$181K | 0.01% | 731 |
|
|
2020
Q4 | $418K | Buy |
31,832
+21,840
| +219% | +$287K | 0.01% | 877 |
|
|
2020
Q3 | $97K | Hold |
9,992
| – | – | ﹤0.01% | 1176 |
|
|
2020
Q2 | $114K | Buy |
+9,992
| New | +$114K | ﹤0.01% | 1132 |
|
|
2017
Q4 | – | Sell |
-30,168
| Closed | -$540K | – | 1132 |
|
|
2017
Q3 | $540K | Sell |
30,168
-700
| -2% | -$12.5K | 0.01% | 845 |
|
|
2017
Q2 | $503K | Hold |
30,868
| – | – | 0.01% | 905 |
|
|
2017
Q1 | $432K | Sell |
30,868
-2,160
| -7% | -$30.2K | 0.01% | 940 |
|
|
2016
Q4 | $527K | Buy |
+33,028
| New | +$527K | 0.01% | 861 |
|